Metropolitan Life Insurance CO Chroma Dex Corp. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.74 - $6.7 $20,027 - $35,878	-5,355 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$6.05 - $10.41 $32,397 - $55,745	5,355 New	5,355 $33,000
Q3 2021 Mar 30, 2023	SELL	$6.05 - $10.41 $44,860 - $77,190	-7,415 Reduced 58.07%	5,355 $33,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $44,860 - $77,190	-7,415 Reduced 58.07%	5,355 $34,000
Q2 2021 Jun 21, 2023	BUY	$6.66 - $10.92 $85,048 - $139,448	12,770 New	12,770 $125,000
Q2 2021 Mar 30, 2023	BUY	$6.66 - $10.92 $10,682 - $17,515	1,604 Added 14.37%	12,770 $125,000
Q2 2021 Aug 16, 2021	BUY	$6.66 - $10.92 $84,974 - $139,328	12,759 Added 115990.91%	12,770 $126,000
Q1 2021 Jun 26, 2023	BUY	$4.59 - $18.74 $51,251 - $209,250	11,166 New	11,166 $104 Million
Q1 2021 Mar 30, 2023	BUY	$4.59 - $18.74 $51,251 - $209,250	11,166 New	11,166 $104,000
Q1 2021 May 14, 2021	BUY	$4.59 - $18.74 $50 - $206	11 New	11 $104,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.